ENDE Biofrontera Investors Key stock information KEY STOCK DATA Share class Registered shares (no par value) Transparency level Prime Standard ISIN DE0006046113 WKN 604611 Ticker symbol B8F Total shares issued 56,717,385 Freefloat ~ 40 % Stock exchanges Xetra, all other German stock exchanges Designated sponsors ICF Bank AG First day of trading October 30, 2006 NASDAQ STOCK EXCHANGE Ticker Symbol BFRA Securities traded ADS (each representing two common shares) Market segment Nasdaq Capital Market First day of trading February 14, 2018 DOWNLOADS IPO Prospectus Securities Prospectus 2018 for the listing on the NASDAQ Capital Market (1.4 MiB) Securities Prospectus for the capital increase announced on January 29, 2018 (2.7 MiB) Supplement No.1 to the Securities Prospectus 2018 (113.2 KiB) Supplement No.2 to the Securities Prospectus 2018 (78.3 KiB) Securities Prospectus for the capital increase announced on October 31, 2016 (2.4 MiB) Supplement No.1 to the Securities Prospectus 2016 (54.9 KiB) Securities Prospectus for the capital increase announced on October 27, 2015 (2.0 MiB) Supplement No.1 to the Securities Prospectus 2015 (537.5 KiB) Supplement No.2 to the Securities Prospectus 2015 (1.4 MiB) Securities Prospectus for the capital increase announced on January 20, 2014 (2.5 MiB) Supplement No.1 to the Securities Prospectus 2014 (66.3 KiB) Announcement pursuant to § 8 (1) sentence 6 of the German Securities Prospectus Act (German only) (183.0 KiB) Summary document for admission to the Regulated Market of the Frankfurt Stock Exchange pursuant to § 4 para. 2 no. 8 lit. d) WpPG (German only) (285.9 KiB) Securities prospectus as of 16 June 2010 (German only) (2.0 MiB) Securities prospectus as of 26 October 2006 (German only) (1.9 MiB) CONTACT Biofrontera AG Hemmelrather Weg 201 51377 Leverkusen +49-214-87632-0 info@biofrontera.com Germany SERVICE Imprint Disclaimer Data Privacy Policy Terms and Conditions (German only) Purchasing conditions (German only) ABOUT BIOFRONTERA We have specialized in dermatology as your skin's health is our concern. We aim to protect and heal your skin with our innovative photodynamic therapy medication. BIOFRONTERA AG © 2021 all rights reserved This site uses third-party website tracking technologies to provide and continually improve our services, and to display advertisements according to users' interests. I agree and may revoke or change my consent at any time with effect for the future. DENY ACCEPT MORE Powered by